摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cycloheptylsulfamate | 60900-58-5

中文名称
——
中文别名
——
英文名称
Cycloheptylsulfamate
英文别名
cycloheptyl sulfamate
Cycloheptylsulfamate化学式
CAS
60900-58-5
化学式
C7H15NO3S
mdl
——
分子量
193.27
InChiKey
NDIAXBSABFWAHX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    77.8
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS
    申请人:Salk Institute for Biological Studies
    公开号:EP3142699A1
    公开(公告)日:2017-03-22
  • [EN] ORNITHINE- OR ASPARTATE-CONTAINING COMPOSITIONS AND THE USES THEREOF<br/>[FR] COMPOSITIONS COMPRENANT DE L'ORNITHINE OU DE L'ASPARTATE ET UTILISATIONS ASSOCIÉES
    申请人:WUHAN QR SCIENCE AND TECHNOLOGY DEV CO
    公开号:WO2014139469A1
    公开(公告)日:2014-09-18
    Methods and compositions comprising ornithine and/or aspartate that are useful for lowering one or more hyperlipidemic risk factor levels are described. More specifically, compositions comprising ornithine and/or aspartate that are useful for lowering lipid and/or lipoprotein levels, such as triglyceride, cholesterol and LDL levels, in the bloodstream in a subject are described. Methods of using compositions comprising ornithine and/or aspartate for ameliorating the side-effect induced by a therapeutic agent (e.g., statin) or a condition that is associated with an elevation of CPK (e.g., rhabdomyolysis or myopathy) are also described.
  • [EN] COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS<br/>[FR] COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE TROUBLES MÉTABOLIQUES
    申请人:SALK INST FOR BIOLOGICAL STUDI
    公开号:WO2015176017A1
    公开(公告)日:2015-11-19
    The disclosure features compositions and methods for treating a metabolic disorder associated with calcitonin gene-related peptide (CGRP), including diabetes, conditions associated with inhibition of insulin secretion, or for increasing longevity. Specifically, the methods comprise administering to a subject suffering a metabolic disorder a therapeutically effective amount of an anti-CGRP antagonist antibody.
  • [EN] ORNITHINE-CONTAINING OR ASPARTATE-CONTAINING COMPOSITIONS AND THE USES THEREOF<br/>[FR] COMPOSITIONS CONTENANT DE L'ORNITHINE OU DE L'ASPARTATE ET LEURS UTILISATIONS
    申请人:WUHAN LL SCIENCE AND TECHNOLOGY DEV CO LTD
    公开号:WO2015161448A1
    公开(公告)日:2015-10-29
    Methods and compositions comprising ornithine and/or aspartate that are useful for lowering serum glucose level, treating diabetes or hyperglycemia are described. Methods of using compositions comprising ornithine and/or aspartate for ameliorating the side-effect induced by a therapeutic agent (e.g., anti-hyperglycemic agents) are also described.
查看更多